

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.97916290 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.05526553 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05526553 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.00320329 |
| 5 | actin nucleation (GO:0045010) | 4.78990851 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.72731556 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.20599775 |
| 8 | response to muramyl dipeptide (GO:0032495) | 4.10485890 |
| 9 | mannose metabolic process (GO:0006013) | 3.93364033 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.86798809 |
| 11 | thymic T cell selection (GO:0045061) | 3.86579321 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.84382801 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82140241 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81140038 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 3.65369946 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64435309 |
| 17 | response to peptidoglycan (GO:0032494) | 3.57792678 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49446508 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.46773097 |
| 20 | T cell selection (GO:0045058) | 3.41933875 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.36390102 |
| 22 | regulation of ARF GTPase activity (GO:0032312) | 3.34364382 |
| 23 | positive T cell selection (GO:0043368) | 3.34164175 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.32237084 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31300619 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31300619 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 3.31300619 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31300619 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 3.31300619 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31300619 |
| 31 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.28130845 |
| 32 | germinal center formation (GO:0002467) | 3.26567079 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.25263078 |
| 34 | negative T cell selection (GO:0043383) | 3.25105809 |
| 35 | detection of bacterium (GO:0016045) | 3.24915936 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23235463 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.20944850 |
| 38 | tolerance induction (GO:0002507) | 3.12762108 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09889982 |
| 40 | detection of other organism (GO:0098543) | 3.08377776 |
| 41 | leukocyte aggregation (GO:0070486) | 3.06496797 |
| 42 | retrograde transport, endosome to Golgi (GO:0042147) | 3.01585194 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93814411 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 2.93691901 |
| 45 | negative regulation of innate immune response (GO:0045824) | 2.92720823 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.92248891 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 2.88839555 |
| 48 | T cell migration (GO:0072678) | 2.88825549 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.86178113 |
| 50 | B cell receptor signaling pathway (GO:0050853) | 2.85403124 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82633506 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 2.82604641 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76911271 |
| 54 | neutrophil activation (GO:0042119) | 2.76007233 |
| 55 | signal complex assembly (GO:0007172) | 2.75270627 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71942330 |
| 57 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.71212395 |
| 58 | Peyers patch development (GO:0048541) | 2.71212395 |
| 59 | granulocyte activation (GO:0036230) | 2.69567002 |
| 60 | regulation of granulocyte differentiation (GO:0030852) | 2.69559264 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.67703047 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.67703047 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67539269 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67104098 |
| 65 | positive regulation of granulocyte differentiation (GO:0030854) | 2.65111833 |
| 66 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63284598 |
| 67 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.62143040 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 2.59686629 |
| 69 | response to interleukin-15 (GO:0070672) | 2.58515904 |
| 70 | defense response to protozoan (GO:0042832) | 2.57708136 |
| 71 | regulation of B cell differentiation (GO:0045577) | 2.56621055 |
| 72 | actin filament polymerization (GO:0030041) | 2.56520787 |
| 73 | type I interferon signaling pathway (GO:0060337) | 2.54463865 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.54463865 |
| 75 | response to type I interferon (GO:0034340) | 2.53105203 |
| 76 | activated T cell proliferation (GO:0050798) | 2.52737783 |
| 77 | respiratory burst (GO:0045730) | 2.51737572 |
| 78 | negative regulation of cell size (GO:0045792) | 2.50282287 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49880594 |
| 80 | positive regulation of histone deacetylation (GO:0031065) | 2.49863108 |
| 81 | activation of MAPKKK activity (GO:0000185) | 2.49457824 |
| 82 | response to protozoan (GO:0001562) | 2.48850008 |
| 83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.47974900 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.47162263 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45667729 |
| 86 | modulation by virus of host process (GO:0019054) | 2.45135940 |
| 87 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.44700005 |
| 88 | regulation of defense response to virus by virus (GO:0050690) | 2.43736120 |
| 89 | histone H4 deacetylation (GO:0070933) | 2.43291445 |
| 90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.43254908 |
| 91 | megakaryocyte development (GO:0035855) | 2.42006184 |
| 92 | positive regulation of protein deacetylation (GO:0090312) | 2.41477606 |
| 93 | detection of external biotic stimulus (GO:0098581) | 2.39558848 |
| 94 | histone H3 deacetylation (GO:0070932) | 2.39035055 |
| 95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.38520736 |
| 96 | regulation of T cell tolerance induction (GO:0002664) | 2.38456486 |
| 97 | cellular response to virus (GO:0098586) | 2.37913501 |
| 98 | activation of JUN kinase activity (GO:0007257) | 2.36603863 |
| 99 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.34767743 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 2.33845259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.23017294 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.81125447 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.72005347 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.70597042 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.68296940 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.46455896 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36384162 |
| 8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.35325137 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30746361 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27223822 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.26761615 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.25295771 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.20463979 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.14571170 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14563110 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.10643580 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09673704 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04512098 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 2.02127392 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.99802455 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99396741 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98220437 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94423130 |
| 24 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.91801161 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88342543 |
| 26 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.84258030 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83788883 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80249481 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76392456 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72443972 |
| 31 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.70951495 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69811758 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.66501893 |
| 34 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.62655033 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62466908 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58574445 |
| 37 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57179512 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56661267 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56204401 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55067652 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54161723 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52150063 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50318748 |
| 44 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.50189557 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50133268 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49889481 |
| 47 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.49865525 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44402597 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43196015 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41610017 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40572814 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37559512 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37362746 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36971574 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35992849 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35852192 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35608345 |
| 58 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.35561849 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34825685 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34803241 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33949572 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32397799 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31996394 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.31830317 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31173679 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31141300 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30601598 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30323826 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29794653 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29191685 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28215208 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.24796381 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24768096 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24051937 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.23551097 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23174074 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20784868 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20707459 |
| 79 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20295501 |
| 80 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18691896 |
| 81 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18165350 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16844751 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15952580 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15816102 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15761457 |
| 86 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14494650 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14195359 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13890889 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13758781 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13509951 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13382597 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13176636 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11263260 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11175003 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10106172 |
| 96 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08717678 |
| 97 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08696417 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06571938 |
| 99 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06028477 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05192824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.03944423 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.60002253 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.46562535 |
| 4 | MP0003724_increased_susceptibility_to | 3.10368340 |
| 5 | MP0003303_peritoneal_inflammation | 2.86308555 |
| 6 | MP0005671_abnormal_response_to | 2.85028994 |
| 7 | MP0009278_abnormal_bone_marrow | 2.82147901 |
| 8 | MP0005451_abnormal_body_composition | 2.60241481 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.57245491 |
| 10 | MP0005025_abnormal_response_to | 2.54736263 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.46857225 |
| 12 | MP0008260_abnormal_autophagy | 2.46837736 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.46484453 |
| 14 | MP0002419_abnormal_innate_immunity | 2.44170422 |
| 15 | MP0001800_abnormal_humoral_immune | 2.42382143 |
| 16 | MP0000685_abnormal_immune_system | 2.36057197 |
| 17 | MP0001790_abnormal_immune_system | 2.31551521 |
| 18 | MP0005387_immune_system_phenotype | 2.31551521 |
| 19 | MP0002723_abnormal_immune_serum | 2.29099277 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.23678723 |
| 21 | MP0001819_abnormal_immune_cell | 2.22968792 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.20718905 |
| 23 | MP0004947_skin_inflammation | 2.19110720 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.13936100 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.11225632 |
| 26 | MP0009785_altered_susceptibility_to | 2.09672301 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.99064633 |
| 28 | MP0009840_abnormal_foam_cell | 1.92584145 |
| 29 | MP0002398_abnormal_bone_marrow | 1.88678473 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.79051408 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.78404759 |
| 32 | MP0000716_abnormal_immune_system | 1.76433167 |
| 33 | MP0002405_respiratory_system_inflammati | 1.75448543 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.69256015 |
| 35 | MP0006082_CNS_inflammation | 1.63790642 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.62819254 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.62819254 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.60734772 |
| 39 | MP0002722_abnormal_immune_system | 1.54947512 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.54409957 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.51566949 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.51085084 |
| 43 | MP0001873_stomach_inflammation | 1.49630141 |
| 44 | MP0002429_abnormal_blood_cell | 1.48458728 |
| 45 | MP0003866_abnormal_defecation | 1.47538625 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.46904385 |
| 47 | MP0002822_catalepsy | 1.42969036 |
| 48 | MP0002933_joint_inflammation | 1.40379652 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.39530955 |
| 50 | MP0000858_altered_metastatic_potential | 1.33330644 |
| 51 | MP0009764_decreased_sensitivity_to | 1.30741534 |
| 52 | MP0000604_amyloidosis | 1.27177601 |
| 53 | MP0005083_abnormal_biliary_tract | 1.26017282 |
| 54 | MP0004510_myositis | 1.25869891 |
| 55 | MP0004381_abnormal_hair_follicle | 1.22320801 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.21616259 |
| 57 | MP0008469_abnormal_protein_level | 1.21435143 |
| 58 | MP0003329_amyloid_beta_deposits | 1.16010124 |
| 59 | MP0001849_ear_inflammation | 1.09435640 |
| 60 | MP0002132_abnormal_respiratory_system | 1.08939856 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.06017128 |
| 62 | MP0001853_heart_inflammation | 1.05367347 |
| 63 | MP0000678_abnormal_parathyroid_gland | 1.02488013 |
| 64 | MP0000681_abnormal_thyroid_gland | 1.00786250 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 0.97634982 |
| 66 | MP0003075_altered_response_to | 0.91804518 |
| 67 | MP0005310_abnormal_salivary_gland | 0.90930514 |
| 68 | MP0003690_abnormal_glial_cell | 0.86218939 |
| 69 | MP0008874_decreased_physiological_sensi | 0.85564250 |
| 70 | MP0003879_abnormal_hair_cell | 0.80953785 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.80545606 |
| 72 | MP0005535_abnormal_body_temperature | 0.80286185 |
| 73 | MP0005390_skeleton_phenotype | 0.79714944 |
| 74 | MP0001663_abnormal_digestive_system | 0.79195581 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.78570354 |
| 76 | MP0005375_adipose_tissue_phenotype | 0.75930026 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.74300777 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.72835656 |
| 79 | MP0004858_abnormal_nervous_system | 0.72440675 |
| 80 | MP0004130_abnormal_muscle_cell | 0.72364577 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 0.70562877 |
| 82 | MP0001851_eye_inflammation | 0.69768954 |
| 83 | MP0009763_increased_sensitivity_to | 0.69604032 |
| 84 | MP0002396_abnormal_hematopoietic_system | 0.68004567 |
| 85 | MP0002249_abnormal_larynx_morphology | 0.67564493 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.67554421 |
| 87 | MP0005166_decreased_susceptibility_to | 0.66510203 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.65585488 |
| 89 | MP0000609_abnormal_liver_physiology | 0.65580414 |
| 90 | MP0001764_abnormal_homeostasis | 0.65543288 |
| 91 | MP0003795_abnormal_bone_structure | 0.63137332 |
| 92 | MP0008995_early_reproductive_senescence | 0.61752931 |
| 93 | MP0000490_abnormal_crypts_of | 0.61450994 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.60219626 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.59153506 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.58379975 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.57415926 |
| 98 | MP0009931_abnormal_skin_appearance | 0.57267775 |
| 99 | MP0003787_abnormal_imprinting | 0.55648920 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.55453942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.47127711 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 3.72431168 |
| 3 | Obstructive lung disease (HP:0006536) | 3.72431168 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.68735695 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.51551280 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.50018408 |
| 7 | Myositis (HP:0100614) | 3.48482457 |
| 8 | Increased IgE level (HP:0003212) | 3.43535945 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.33596741 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.32638262 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.13039777 |
| 12 | J-shaped sella turcica (HP:0002680) | 3.12618892 |
| 13 | Recurrent fungal infections (HP:0002841) | 2.97992828 |
| 14 | Prolonged bleeding time (HP:0003010) | 2.97831992 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 2.94405852 |
| 16 | Obstructive sleep apnea (HP:0002870) | 2.94223754 |
| 17 | Purpura (HP:0000979) | 2.92676395 |
| 18 | Meningitis (HP:0001287) | 2.91536847 |
| 19 | Hemorrhage of the eye (HP:0011885) | 2.91360175 |
| 20 | Orchitis (HP:0100796) | 2.88812494 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.87686820 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.87686820 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.87686820 |
| 24 | Reticulocytosis (HP:0001923) | 2.81280045 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.80414791 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.80414791 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.80414791 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 2.71853141 |
| 29 | Mucopolysacchariduria (HP:0008155) | 2.71738608 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71738608 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71186577 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65763148 |
| 33 | Colitis (HP:0002583) | 2.65111496 |
| 34 | Cellulitis (HP:0100658) | 2.64285079 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.63882470 |
| 36 | Optic neuritis (HP:0100653) | 2.63882470 |
| 37 | Stomatitis (HP:0010280) | 2.63236771 |
| 38 | Granulocytopenia (HP:0001913) | 2.62723395 |
| 39 | Broad face (HP:0000283) | 2.62482187 |
| 40 | Pustule (HP:0200039) | 2.61065552 |
| 41 | Petechiae (HP:0000967) | 2.58051620 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57292535 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.55902354 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.52580208 |
| 45 | Gingivitis (HP:0000230) | 2.50765347 |
| 46 | Hypertensive crisis (HP:0100735) | 2.49537624 |
| 47 | Vasculitis (HP:0002633) | 2.48323014 |
| 48 | Increased serum ferritin (HP:0003281) | 2.47252791 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.45463049 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.37472658 |
| 51 | Stridor (HP:0010307) | 2.37061155 |
| 52 | Seborrheic dermatitis (HP:0001051) | 2.36426671 |
| 53 | Loss of speech (HP:0002371) | 2.36186466 |
| 54 | Encephalitis (HP:0002383) | 2.31870717 |
| 55 | Epistaxis (HP:0000421) | 2.31057713 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 2.29771976 |
| 57 | Recurrent viral infections (HP:0004429) | 2.28482798 |
| 58 | Easy fatigability (HP:0003388) | 2.28204862 |
| 59 | Cholecystitis (HP:0001082) | 2.27391409 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.27391409 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.27137625 |
| 62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.26723567 |
| 63 | Increased IgM level (HP:0003496) | 2.23002628 |
| 64 | Chest pain (HP:0100749) | 2.18394657 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.18135780 |
| 66 | Recurrent skin infections (HP:0001581) | 2.18037744 |
| 67 | Hyperthyroidism (HP:0000836) | 2.15957937 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.15502055 |
| 69 | Atelectasis (HP:0100750) | 2.15352140 |
| 70 | Urticaria (HP:0001025) | 2.13792457 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.13293922 |
| 72 | Thin bony cortex (HP:0002753) | 2.12410068 |
| 73 | Cervical subluxation (HP:0003308) | 2.10461781 |
| 74 | Myopathic facies (HP:0002058) | 2.10435476 |
| 75 | Peripheral hypomyelination (HP:0007182) | 2.08307982 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 2.08029401 |
| 77 | Hypochromic anemia (HP:0001931) | 2.05111248 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 2.03874703 |
| 79 | Hemoptysis (HP:0002105) | 2.02676791 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.00816211 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 2.00566520 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00237591 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00237591 |
| 84 | Spinal canal stenosis (HP:0003416) | 1.99868301 |
| 85 | Hepatosplenomegaly (HP:0001433) | 1.99046245 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 1.96909049 |
| 87 | Truncus arteriosus (HP:0001660) | 1.96755753 |
| 88 | Ragged-red muscle fibers (HP:0003200) | 1.95454731 |
| 89 | Leukocytosis (HP:0001974) | 1.93598100 |
| 90 | Abnormality of lateral ventricle (HP:0030047) | 1.93303195 |
| 91 | Spontaneous hematomas (HP:0007420) | 1.92108486 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.92084627 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 1.92017580 |
| 94 | Ankle clonus (HP:0011448) | 1.90146936 |
| 95 | Emphysema (HP:0002097) | 1.88981220 |
| 96 | Combined immunodeficiency (HP:0005387) | 1.86461360 |
| 97 | Abnormality of the fingertips (HP:0001211) | 1.86113986 |
| 98 | Biconcave vertebral bodies (HP:0004586) | 1.85130071 |
| 99 | Acne (HP:0001061) | 1.84604384 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83152196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.37521219 |
| 2 | RIPK4 | 2.87653155 |
| 3 | TRIB3 | 2.83728146 |
| 4 | ERN1 | 2.67250303 |
| 5 | TNK2 | 2.40608531 |
| 6 | MAP3K11 | 2.22009848 |
| 7 | SIK2 | 2.19530510 |
| 8 | PRPF4B | 2.18588001 |
| 9 | MAP2K3 | 2.10801353 |
| 10 | SIK1 | 2.09603567 |
| 11 | GRK6 | 2.02725746 |
| 12 | TESK2 | 1.90373785 |
| 13 | TBK1 | 1.85980037 |
| 14 | FES | 1.73032700 |
| 15 | BLK | 1.70925492 |
| 16 | ZAP70 | 1.67936435 |
| 17 | SIK3 | 1.66139809 |
| 18 | ICK | 1.57558380 |
| 19 | TAOK1 | 1.47479929 |
| 20 | EPHB1 | 1.46772894 |
| 21 | MAP3K14 | 1.46522523 |
| 22 | BTK | 1.45738290 |
| 23 | IRAK3 | 1.44829825 |
| 24 | IRAK4 | 1.43387501 |
| 25 | TYK2 | 1.42968844 |
| 26 | MAP3K13 | 1.38768691 |
| 27 | RIPK1 | 1.38004771 |
| 28 | MARK2 | 1.37696606 |
| 29 | PRKD2 | 1.37411317 |
| 30 | TXK | 1.30794886 |
| 31 | KDR | 1.28600919 |
| 32 | TAOK3 | 1.28176526 |
| 33 | TAOK2 | 1.26108457 |
| 34 | CSK | 1.24329880 |
| 35 | SYK | 1.21233626 |
| 36 | MAP3K7 | 1.18982115 |
| 37 | MAP3K10 | 1.17092137 |
| 38 | MAP2K2 | 1.16993192 |
| 39 | CDC42BPA | 1.14869956 |
| 40 | JAK3 | 1.14015817 |
| 41 | IKBKE | 1.12285629 |
| 42 | DYRK1B | 1.12215521 |
| 43 | FGFR4 | 1.06967257 |
| 44 | IKBKB | 1.05689537 |
| 45 | BCKDK | 1.04006169 |
| 46 | MAP3K1 | 1.02959678 |
| 47 | NME2 | 1.02728902 |
| 48 | HCK | 0.96741685 |
| 49 | CAMKK1 | 0.95360122 |
| 50 | MAP3K3 | 0.94498945 |
| 51 | MAP3K6 | 0.93343688 |
| 52 | MAP2K6 | 0.91333043 |
| 53 | RPS6KC1 | 0.90114024 |
| 54 | RPS6KL1 | 0.90114024 |
| 55 | TESK1 | 0.88972730 |
| 56 | SMG1 | 0.88915807 |
| 57 | PKN2 | 0.88702935 |
| 58 | CSF1R | 0.87301960 |
| 59 | MATK | 0.87073948 |
| 60 | ITK | 0.86362264 |
| 61 | LCK | 0.86034687 |
| 62 | HIPK2 | 0.83311766 |
| 63 | RPS6KA2 | 0.83300213 |
| 64 | LYN | 0.81380320 |
| 65 | TYRO3 | 0.78911592 |
| 66 | BMX | 0.78727930 |
| 67 | PDPK1 | 0.72369527 |
| 68 | RPS6KA6 | 0.71088832 |
| 69 | PDK1 | 0.71082149 |
| 70 | FGR | 0.70515855 |
| 71 | JAK2 | 0.68918734 |
| 72 | MAPK12 | 0.68846278 |
| 73 | PIM2 | 0.66550531 |
| 74 | PTK6 | 0.65500351 |
| 75 | EPHA3 | 0.64678979 |
| 76 | EEF2K | 0.64166361 |
| 77 | CDK12 | 0.60566850 |
| 78 | MARK3 | 0.59342251 |
| 79 | KSR2 | 0.57673250 |
| 80 | MST1R | 0.56085829 |
| 81 | JAK1 | 0.54926001 |
| 82 | MAPK11 | 0.53363676 |
| 83 | MAPK7 | 0.53097248 |
| 84 | CDK4 | 0.49680955 |
| 85 | KIT | 0.49536163 |
| 86 | DAPK2 | 0.49433030 |
| 87 | FYN | 0.48690422 |
| 88 | MAPK3 | 0.41847078 |
| 89 | TTN | 0.41809558 |
| 90 | RET | 0.40955634 |
| 91 | IRAK2 | 0.40121002 |
| 92 | MAPK4 | 0.39074632 |
| 93 | PRKD3 | 0.38410560 |
| 94 | PRKCH | 0.37664592 |
| 95 | PIM1 | 0.37437926 |
| 96 | CHUK | 0.37254875 |
| 97 | MAPK15 | 0.35552188 |
| 98 | MTOR | 0.34806491 |
| 99 | RPS6KA1 | 0.33913860 |
| 100 | PTK2B | 0.33804058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.56568535 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53444428 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37612014 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.36889170 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19765184 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15402197 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.10952287 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.97605618 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.92583804 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88770970 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87935088 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.86508456 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82389163 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81338462 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.78179265 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72938324 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72202544 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.71966363 |
| 19 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.65843101 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57785675 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53998235 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.52919236 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.48048769 |
| 24 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.46300369 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38202861 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35314360 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34494224 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28203008 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26803827 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.24578051 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21634428 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21475084 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21260193 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.19453940 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19288267 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18367744 |
| 37 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.15413550 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14651949 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14642484 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.12936851 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.10583891 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.07581257 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06083125 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05697205 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03459817 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.03110498 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.03087974 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00958402 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00894195 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 0.96839796 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95005555 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.93496551 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.93235707 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.91647258 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.91462810 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90817658 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.84827008 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84628480 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82846924 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81719460 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81500360 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81269575 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81262465 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79760668 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79739297 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.79092047 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78471726 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77809856 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77201971 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75640040 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73544142 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.70811175 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70547879 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68042960 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67815292 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65547835 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64627533 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.63175141 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.62174519 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.62076246 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59544938 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57158836 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.56570431 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55096389 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54858147 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54313079 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54106094 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53691400 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51683313 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50032600 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50002792 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49864054 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49696261 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49481604 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48876632 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48525821 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48405584 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47522867 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46411841 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42639303 |

